Home Applications 205677 Application 205677
Type NDA
Sponsor VANDA PHARMS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 HETLIOZ TASIMELTEON CAPSULE;ORAL 20MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205677-001 HETLIOZ TASIMELTEON 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N205677-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 48 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N205677-001 ODE-330 2027-12-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 c2088c7a36db…2026-09-14 22:38:34 2026-08 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N205677-001 HETLIOZ 20MG CAPSULE / ORAL RLD, RS 2014-01-31 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N205677-001 HETLIOZ 20MG CAPSULE / ORAL AB RLD, RS 2014-01-31 3bdfa0b2c4d7…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 8 of 39 · 1,556 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 11566011 2035-02-12 Drug substance, Drug product 2023-02-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 11760740 2035-02-12 Drug substance, Drug product 2023-10-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 12049457 2035-02-12 Drug substance, Drug product 2024-08-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 10376487 2035-07-27 U-2615 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 10376487 2035-07-27 U-3007 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 10179119 2035-08-29 U-3003 2020-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 11266622 2035-08-29 U-3003 2022-06-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205677-001 11759446 2041-02-21 U-3003 2023-10-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205677-001 10149829 2033-01-25 U-2477 2018-12-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 10149829 2033-01-25 U-3006 2018-12-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 10449176 2033-01-25 U-2149 2019-11-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 10610510 2033-01-25 U-3009 2020-05-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 10610510 2033-01-25 U-2805 2020-05-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 10945988 2033-01-25 U-2149 2021-03-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 10980770 2033-01-25 U-3106 2021-04-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 10980770 2033-01-25 U-3107 2021-04-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11285129 2033-01-25 U-3342 2022-04-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11285129 2033-01-25 U-3343 2022-04-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11633377 2033-01-25 U-2149 2023-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11633377 2033-01-25 U-3003 2023-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11826339 2033-01-25 U-3342 2024-04-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11826339 2033-01-25 U-3343 2024-04-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11833130 2033-01-25 U-2149 2024-01-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11833130 2033-01-25 U-3003 2024-01-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11850229 2033-01-25 U-3342 2024-01-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11850229 2033-01-25 U-3343 2024-01-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11918557 2033-01-25 U-3003 2024-04-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11918557 2033-01-25 U-3865 2024-04-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 12201604 2033-01-25 U-3003 2025-02-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 12201604 2033-01-25 U-3865 2025-02-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 9060995 2033-01-25 U-1710 2015-06-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 9539234 2033-01-25 U-1934 2017-01-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 9539234 2033-01-25 U-3004 2017-01-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 9549913 2033-01-25 U-1486 2017-01-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 9855241 2033-01-25 U-2149 2018-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 RE46604 2033-01-25 U-2147 2017-11-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11918556 2033-04-07 U-3342 2024-04-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 11918556 2033-04-07 U-3343 2024-04-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 9730910 2034-05-17 U-2085 2017-08-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205677-001 9730910 2034-05-17 U-3005 2017-08-22 6a471c1ec25d…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 69 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 43068-220 Hetlioz tasimelteon Vanda Pharmaceuticals Inc. NDA Current 43068-220 Hetlioz tasimelteon Vanda Pharmaceuticals Inc. NDA Current 43068-220 Hetlioz tasimelteon Vanda Pharmaceuticals Inc. NDA Current 43068-220 Hetlioz tasimelteon Vanda Pharmaceuticals Inc. NDA Current 43068-220 Hetlioz tasimelteon Vanda Pharmaceuticals Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 65463 SUPPL 2020-12-02 65460 SUPPL 2020-12-01 60463 SUPPL 2019-10-09 60272 SUPPL 2019-10-07 40496 SUPPL 2014-12-16 10488 SUPPL 2014-12-16 40494 ORIG 2014-10-03 24501 ORIG 2014-03-07 22999 ORIG 2014-03-07 10487 ORIG 2014-02-03 40495 ORIG 2014-01-31